Therefore, it is important to determine the effect of GLP‐1 RAs on the improvement in fibrosis when evaluating their role in the treatment of NAFLD.24, 25, 50. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.